[go: up one dir, main page]

GB9615976D0 - The use of proteinase inhibitors for the prevention or reduction of bone resorption - Google Patents

The use of proteinase inhibitors for the prevention or reduction of bone resorption

Info

Publication number
GB9615976D0
GB9615976D0 GBGB9615976.9A GB9615976A GB9615976D0 GB 9615976 D0 GB9615976 D0 GB 9615976D0 GB 9615976 A GB9615976 A GB 9615976A GB 9615976 D0 GB9615976 D0 GB 9615976D0
Authority
GB
United Kingdom
Prior art keywords
prevention
reduction
bone resorption
proteinase inhibitors
proteinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9615976.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunshine Enterprise Holding AS
Original Assignee
Center for Clinical and Basic Research AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Center for Clinical and Basic Research AS filed Critical Center for Clinical and Basic Research AS
Priority to GBGB9615976.9A priority Critical patent/GB9615976D0/en
Publication of GB9615976D0 publication Critical patent/GB9615976D0/en
Priority to IL14529797A priority patent/IL145297A0/xx
Priority to AU42032/97A priority patent/AU733104B2/en
Priority to IL12810397A priority patent/IL128103A0/xx
Priority to CN97196863A priority patent/CN1226174A/zh
Priority to EP97940041A priority patent/EP0915709A1/en
Priority to BR9710615-1A priority patent/BR9710615A/pt
Priority to PCT/EP1997/004110 priority patent/WO1998004287A1/en
Priority to JP10508510A priority patent/JP2001501594A/ja
Priority to CA002261567A priority patent/CA2261567A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9615976.9A 1996-07-30 1996-07-30 The use of proteinase inhibitors for the prevention or reduction of bone resorption Pending GB9615976D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9615976.9A GB9615976D0 (en) 1996-07-30 1996-07-30 The use of proteinase inhibitors for the prevention or reduction of bone resorption
CA002261567A CA2261567A1 (en) 1996-07-30 1997-07-29 The use of proteinase inhibitors for prevention or reduction of bone resorption
CN97196863A CN1226174A (zh) 1996-07-30 1997-07-29 应用蛋白酶抑制剂预防或降低骨的吸收
AU42032/97A AU733104B2 (en) 1996-07-30 1997-07-29 The use of proteinase inhibitors for prevention or reduction of bone resorption
IL12810397A IL128103A0 (en) 1996-07-30 1997-07-29 The use of proteinase inhibitors for prevention or reduction of bone resorption
IL14529797A IL145297A0 (en) 1996-07-30 1997-07-29 Use of an agent for the manufacture of a medicament for the treatment of bone diseases
EP97940041A EP0915709A1 (en) 1996-07-30 1997-07-29 The use of proteinase inhibitors for prevention or reduction of bone resorption
BR9710615-1A BR9710615A (pt) 1996-07-30 1997-07-29 Uso de um agente na manufatura de um medicamento para o tratamento de doença metabólica óssea, e, agente de anti-absorção óssea.
PCT/EP1997/004110 WO1998004287A1 (en) 1996-07-30 1997-07-29 The use of proteinase inhibitors for prevention or reduction of bone resorption
JP10508510A JP2001501594A (ja) 1996-07-30 1997-07-29 骨吸収を防止もしくは減少させるためのプロテイナーゼ阻害剤の用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615976.9A GB9615976D0 (en) 1996-07-30 1996-07-30 The use of proteinase inhibitors for the prevention or reduction of bone resorption

Publications (1)

Publication Number Publication Date
GB9615976D0 true GB9615976D0 (en) 1996-09-11

Family

ID=10797737

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9615976.9A Pending GB9615976D0 (en) 1996-07-30 1996-07-30 The use of proteinase inhibitors for the prevention or reduction of bone resorption

Country Status (9)

Country Link
EP (1) EP0915709A1 (zh)
JP (1) JP2001501594A (zh)
CN (1) CN1226174A (zh)
AU (1) AU733104B2 (zh)
BR (1) BR9710615A (zh)
CA (1) CA2261567A1 (zh)
GB (1) GB9615976D0 (zh)
IL (1) IL128103A0 (zh)
WO (1) WO1998004287A1 (zh)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061623A1 (en) * 1999-04-09 2000-10-19 Human Genome Sciences, Inc. 62 human secreted proteins
US6277061B1 (en) 1998-03-31 2001-08-21 The Research Foundation Of State University Of New York Method of inhibiting membrane-type matrix metalloproteinase
US6352976B1 (en) 1998-12-31 2002-03-05 Aventis Pharmaceuticals Inc. Selective inhibitors of MMP-12
DK1140984T3 (da) * 1998-12-31 2003-05-26 Aventis Pharma Inc Selektive inhibitorer af MMP-12
FR2802945A1 (fr) * 1999-12-28 2001-06-29 Pf Medicament Nouvelle metalloprotease matricielle mmp-25 homologue de la matrilysine
US7232796B2 (en) 2000-04-05 2007-06-19 Ipf Pharmaceuticals Gmbh Medicament containing a tissue inhibitor of metalloproteinases-2 (TIMP-2) as an osteoanabolically active substance
EP1288297A4 (en) * 2000-05-19 2004-11-17 Daiichi Fine Chem Co Ltd REGULATION OF MT1-MMP ACTIVITY
US7041787B2 (en) 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US6906036B2 (en) 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7094754B2 (en) 2001-08-16 2006-08-22 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
CA2493232A1 (en) * 2002-07-18 2004-01-29 Index Pharmaceuticals Ab Antisense compounds, methods and compositions for treating mmp-12 related inflammatory disorders
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds
WO2007079218A2 (en) 2005-12-30 2007-07-12 Dyax Corp. Metalloproteinase binding proteins
JP2011506614A (ja) * 2007-12-17 2011-03-03 ダイアックス コーポレーション Mmp−14結合タンパク質を含む、骨溶解性障害を処置するための組成物および方法
EP2262530A4 (en) * 2008-03-03 2012-12-05 Dyax Corp Metalloproteinase-12 TIE PROTEINS
WO2013059439A2 (en) 2011-10-21 2013-04-25 Dyax Corp. Combination therapy comprising an mmp-14 binding protein
EP2907512A1 (en) 2014-02-14 2015-08-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Inhibitors of MMP-12 as antiviral Agents
KR101576904B1 (ko) * 2014-07-31 2015-12-14 (주)케어젠 파골세포 분화 및 활성 억제능을 갖는 펩타이드 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2848232B2 (ja) * 1993-02-19 1999-01-20 武田薬品工業株式会社 アルデヒド誘導体
EP0685557B1 (en) * 1993-11-30 1998-08-12 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel metalloprotease and dna coding for the same

Also Published As

Publication number Publication date
EP0915709A1 (en) 1999-05-19
AU4203297A (en) 1998-02-20
CA2261567A1 (en) 1998-02-05
CN1226174A (zh) 1999-08-18
WO1998004287A1 (en) 1998-02-05
IL128103A0 (en) 1999-11-30
BR9710615A (pt) 2000-01-11
AU733104B2 (en) 2001-05-10
JP2001501594A (ja) 2001-02-06

Similar Documents

Publication Publication Date Title
GB9615976D0 (en) The use of proteinase inhibitors for the prevention or reduction of bone resorption
AU3359697A (en) Bone resorption inhibitors
PL331900A1 (en) 1,4-heterocyclic inhibitors of metaloprotease
GB9416078D0 (en) Ice inhibitor
PL331838A1 (en) 1,3-diheterocyclic inhibitors of metaloproteases
PL331338A1 (en) Thiosulphonamidic metaloprotease inhibitors
DE69533256D1 (en) Chimäre komplement inhibitor proteine
GB9800795D0 (en) Prevention of multiple use of limited use devices
HUP9901053A3 (en) Disinfecting compositions and processes for disinfecting surfaces
IL125237A0 (en) Disinfecting compositions and processes for disinfecting surfaces
IL111224A0 (en) Methods for inhibiting bone loss
IL118196A0 (en) Methods for inhibiting bone loss
HU0900792D0 (en) Use of renin-angiotensin inhibitors
PL331803A1 (en) Bidonoric metaloprotease inhibitors
EP0913404A4 (en) DIFFERENTIATION INHIBITOR
IL125307A0 (en) Disinfecting compositions and processes for disinfecting surfaces
AU1486997A (en) An agent promoting bone formation and inhibiting bone resorption
EP1148877A4 (en) METHOD FOR INHIBITING BONE RESORPTION
ZA97252B (en) Compositions for the prevention and treatment of osteoporosis.
AU1255597A (en) An agent promoting bone formation and inhibiting bone resorption
DE69523450D1 (en) Inhibitor
GB9810127D0 (en) Prevention of surgical adhesions
GB9809791D0 (en) Methods of inhibiting bone resorption
GB9810885D0 (en) Methods of inhibiting bone resorption
GB9822699D0 (en) Methods of inhibiting bone resorption